The use of insulin degludec in the secondary care setting: the Dudley experience

被引：0
|
作者：
Khan, A. [1 ]
Kalidindi, S. [1 ]
Siddique, H. [1 ]
机构：
[1] Russells Hall Hosp NHS Trust, Diabet & Endocrinol, Dudley, England
来源：
DIABETIC MEDICINE | 2016年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P200
引用
收藏
页码：94 / 94
页数：1
相关论文
共 50 条
  • [21] Use of antipsychotics (AP) in mental health secondary care setting vs primary care
    Layton, Deborah
    Osborne, Vicki
    Davies, Miranda
    Ratcliffe, Ian
    Clarke, Sarah
    Shakir, Saad Aw
    Reilly, Joe
    Hale, Tony
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 122 - 123
  • [22] A Review of Insulin Degludec/Insulin Aspart: Pharmacokinetic and Pharmacodynamic Properties and Their Implications in Clinical Use
    Hanne Haahr
    Edmond G. Fita
    Tim Heise
    Clinical Pharmacokinetics, 2017, 56 : 339 - 354
  • [23] A Review of Insulin Degludec/Insulin Aspart: Pharmacokinetic and Pharmacodynamic Properties and Their Implications in Clinical Use
    Haahr, Hanne
    Fita, Edmond G.
    Heise, Tim
    CLINICAL PHARMACOKINETICS, 2017, 56 (04) : 339 - 354
  • [24] Treat to target? Efficacy of insulin use in patients with Type 2 diabetes (T2DM) in a secondary care setting
    Muraleedharan, V.
    Caddick, L.
    Hardisty, C.
    Tesfaye, S.
    Scott, A.
    DIABETIC MEDICINE, 2007, 24 : 75 - 75
  • [25] USE OF SCHEDULE OF RECENT EXPERIENCE QUESTIONNAIRE IN AN INSTITUTIONAL HEALTH CARE SETTING
    CASEY, RL
    THORESEN, AR
    SMITH, FJ
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 1970, 14 (02) : 149 - &
  • [26] Palliative care in end-stage heart failure: experience of a collaborative approach in a secondary care setting
    Anscombe, Russell
    Middlemiss, Tom
    INTERNAL MEDICINE JOURNAL, 2019, 49 (03) : 404 - +
  • [27] Insulin degludec/liraglutide in type 2 diabetes: a profile of its use
    Heo, Young-A
    DRUGS & THERAPY PERSPECTIVES, 2020, 36 (06) : 219 - 229
  • [28] An audit of insulin degludec use from an inner city teaching hospital
    Bakhit, M.
    Davies, Z. C.
    Mustafa, O. G.
    DIABETIC MEDICINE, 2018, 35 : 90 - 90
  • [29] Insulin degludec/liraglutide in type 2 diabetes: a profile of its use
    Young-A Heo
    Drugs & Therapy Perspectives, 2020, 36 : 219 - 229
  • [30] The Experience of our Center in Patients Undergoing Insulin Degludec/Insulin Aspart Co-formulation Therapy
    Altay, Feride Pinar
    Farzaliyeva, Aydan
    Iyidir, Ozlem Turhan
    Bozkus, Yusuf
    Kirnap, Nazli Guelsoy
    Kut, Altug
    Nar, Asli
    Tutuncu, Neslihan Bascil
    ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS, 2023, 23 (06) : 826 - 831
12345